Durgical
EN
Open the app

Other antineoplastics (differentiating agents, asparaginases, proteasome inhibitors)

Cancer drugs with their own mechanisms: tretinoin and arsenic make APL cells mature, asparaginase starves leukaemia cells, bortezomib blocks the proteasome.

Updated

What they are

A mixed group: the differentiating agents tretinoin and arsenic trioxide for acute promyelocytic leukaemia (APL), the enzymes asparaginase and pegaspargase for acute lymphoblastic leukaemia, and the proteasome inhibitor bortezomib for multiple myeloma.

Mechanism of action

In APL the PML-RARα fusion protein blocks myeloid maturation; tretinoin (at high levels) and arsenic trioxide both lead to its degradation, so the leukaemic promyelocytes mature. Asparaginase breaks down circulating asparagine, which leukaemic lymphoblasts cannot make well enough. Bortezomib blocks the proteasome, so damaged and regulatory proteins pile up and the myeloma cell dies.

Target: PML-RARα (APL), plasma asparagine, the proteasome

Drugs in this class

Others in the class

  • carfilzomib
  • ixazomib
  • calaspargase pegol

Test yourself

Think of the answer, then tap the question to see it.

Which translocation defines the leukaemia treated with tretinoin and arsenic trioxide?

t(15;17), which creates the PML-RARα fusion in acute promyelocytic leukaemia.

Why are leukaemic lymphoblasts sensitive to asparaginase?

They lack enough asparagine synthetase and depend on asparagine from the plasma, which the enzyme destroys.

Which toxicity most often limits bortezomib?

Peripheral neuropathy.

Add to my cards (3)

More Pharmacology questions →

← All of pharmacology

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: DailyMed - TRETINOIN capsule (DailyMed (U.S. National Library of Medicine), 2026); DailyMed - ARSENIC TRIOXIDE injection (DailyMed (U.S. National Library of Medicine), 2026); DailyMed - BORTEZOMIB injection, powder, lyophilized, for solution (DailyMed (U.S. National Library of Medicine), 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.